Exclusive License Agreement by and between SELLAS LIFE SCIENCES GROUP, Inc., SLSG Limited, LLC, and 3D medicines INC. December 7, 2020Exclusive License Agreement • January 28th, 2021 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
This Exclusive License Agreement (this “Agreement”) is entered into as of the 7th day of December, 2020 (the “Effective Date”), by and among SELLAS Life Sciences Group, Inc., a Delaware corporation with an office address located at Times Square Tower, 7 Times Square, Suite 2503, New York, New York 10036, United States of America (“SELLAS Parent”), SLSG Limited, LLC, a Delaware limited liability company with an office address located at Times Square Tower, 7 Times Square, Suite 2503, New York, New York 10036, United States of America (“SELLAS Sub,” and together with SELLAS Parent and its other Affiliates, “SELLAS”), and 3D Medicines Inc., a corporation organized under the laws of the Cayman Islands with its legal address located at Cricket Square, Hutchins Drive, P.O. Box 2681, Grand Cayman KY1-1111, Cayman Islands (“3DMed”). SELLAS and 3DMed are each referred to herein by name or as a “Party” or, collectively, as “Parties.”
